Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic Patients
Fangping Ding(Capital Medical University), Jiawei Jin(Capital Medical University), Yingfei Wang(Southwestern Medical Center), Qingkun Song(Beijing YouAn Hospital), Jie Sun(Capital Medical University), Yingmin Ma(Capital Medical University), Liu Yang(China-Japan Friendship Hospital), Wenhui Cao(Capital Medical University), Cai-Xia Hu(Capital Medical University), Jing Han(Hebei Medical University), Weiwei Kang(Capital Medical University)
Cited by 2
Related Papers
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
|Blood|2019|307
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke
|JAMA|2023|209
Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke
|JAMA|2022|185
Stretchable Energy‐Harvesting Tactile Interactive Interface with Liquid‐Metal‐Nanoparticle‐Based Electrodes
|Advanced Functional Materials|2020|167
Cascaded metasurfaces for high-purity vortex generation
|Nature Communications|2023|117